StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) stock

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.28−0.05 (-3.76%)

Close on Nov 13, 2026Market cap $217.02MP/E –Yield –

Cabaletta Bio operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for Cabaletta Bio

Cabaletta Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cabaletta Bio figures

See a number that looks wrong?